Barclays analyst Lauren Lieberman lowered the firm’s price target on Clorox (CLX) to $129 from $134 and keeps an Underweight rating on the shares post the earnings report. The company’s categories declined in the second half of the quarter and are expected to remain weak, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLX:
- Clorox Earnings Call: Balancing Growth and Challenges
- Clorox Faces Challenges with Slower Growth and Market Share Losses, Analyst Maintains Hold Rating
- Clorox price target lowered to $140 from $150 at Evercore ISI
- Clorox price target lowered to $150 from $165 at Morgan Stanley
- Clorox price target lowered to $145 from $150 at BofA